Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Adjuvant bisphosphonate therapy should be considered for discussion with all postmenopausal patients, whether their menopause is natural or induced by therapy, who have primary Breast Cancer / Mammacarcinoma. This discussion is important regardless of the patient's hormone receptor status or human epidermal growth factor receptor 2 status, as long as they are candidates for receiving adjuvant systemic therapy. Adjuvant bisphosphonate therapy offers benefits that differ based on the underlying risk of recurrence, and it is linked to a modest enhancement in overall survival.
Adjuvant [bisphosphonates](brain://rRMVob93r…